Previous studies indicated that ITGB2‐AS1 could promote progression, migration and invasion in many types of cancers, including pancreatic ductal adenocarcinoma, renal cell carcinoma, osteosarcoma and breast cancer.15, 16, 17, 18. Here, ITGB2 is linked to breast cancer.